EcoDrugPlus

Tubulin Alpha 4a

Ensembl ID : ENSBBBG00000024643
Gene Symbol: TUBA4A
3 Cross references
225 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSBBBG00000006604
Gene Symbol: LOC104998531
2 Cross references
128 Possible Orthologues:

Tubulin Alpha-3 Chain-Like

Ensembl ID : ENSBBBG00000022456
Gene Symbol: LOC104984835
2 Cross references
139 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSBBBG00000024089
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSBBBG00000016440
Gene Symbol: TUBB3
2 Cross references
154 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSBBBG00000000506
Gene Symbol: TUBB4A
3 Cross references
89 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSBBBG00000013655
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSBBBG00000012045
Gene Symbol: TP53
3 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSBBBG00000016700
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSBBBG00000003878
Gene Symbol: TYK2
3 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSBBBG00000009641
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSBBBG00000001047
Gene Symbol: UTS2R
3 Cross references
92 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).